Focosi D, Maggi F, McConnell S, Casadevall A, et al. Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis. Antiviral Res 2022;198:105247.
PMID: 35033572